Effects of gender on capecitabine toxicity in colorectal cancer
Conclusion
Female colorectal cancer patients experience a higher dose-limiting toxicity incidence than male patients when given adjuvant capecitabine dosed according to body surface area.
Source: Journal of Oncology Pharmacy Practice - Category: Cancer & Oncology Authors: Ilich, A. I., Danilak, M., Kim, C. A., Mulder, K. E., Spratlin, J. L., Ghosh, S., Chambers, C. R., Sawyer, M. B. Tags: Original Articles Source Type: research
More News: Cancer | Cancer & Oncology | Colorectal Cancer | Databases & Libraries | Toxicology | Women | Xeloda